KR

Khalda Rahman

Active Director Director DIN 07866490
DIN 07866490 First appointment Jul 2017 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2017
Shareholding value •••• Premium profile

About Khalda Rahman

Data last updated:

Khalda Rahman is a Director at Maclet Pharmaceuticals Private Limited (since 2017). The company operates in Trading. Maclet Pharmaceuticals Private Limited reported revenue of ₹81,340 (FY 2024).

DIN 07866490
Primary Designation Director
Industry Trading
First Appointment 11 Jul 2017
Oldest Company Age 9 yrs
Largest company Maclet Pharmaceuticals Private Limited · ₹81,340 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jul 20172017₹81,340 (FY 2024)Active

Board colleagues of Khalda Rahman

NameDINCompanyDesignation
Syed Arhamur Rahman07866497Maclet Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Maclet Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Khalda Rahman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Khalda Rahman

Khalda Rahman currently holds 1 directorship: Maclet Pharmaceuticals Private Limited (Director, since 11 Jul 2017, revenue ₹81,340 (FY 2024)).

Khalda Rahman was first appointed on 11 Jul 2017 as Director at Maclet Pharmaceuticals Private Limited.

The current boards of Khalda Rahman's companies include Syed Arhamur Rahman (Maclet Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available